Ki-67 proliferation index and gastric cancer: Answers or more questions

Journal of Surgical Oncology

Volumn 102, Issue 3, 2010, Pages 199-200

  Arciero, Cletus A ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ANTIGENICITY; CANCER STAGING; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER;

CELL PROLIFERATION; HUMANS; KI-67 ANTIGEN; PROGNOSIS; STOMACH NEOPLASMS;

EID: 77956386799     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21626     Document Type: Editorial

References (5)

1. Lee HE, Kim MA, Lee BL, et al.: Low Ki-67Index is an indicator of poor prognosis in gastric cancer. J Surg Oncol 2010;101.
2. Salehi F, Agur A, Scheithauer BW, et al.: Ki-67 in pituitary neoplasms: A review - Part I. Neurosurgery 2009;65:429-437.
3. Stuart-Harris R, Caldas C, Pinder SE, et al.: Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients. Breast 2008;17:323-334.
4. Allegra CJ, Paik S, Colangela LH, et al.: Prognostic value of thymidylate synthase, Ki-67, and -53 in patients with Dukes' B and C colon cancer: A National Cancer Institute - National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 2003;21:241-250. (Pubitemid 46606152)
5. Garrity MM, Burgart LJ, Mahoney MR, et al.: Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: A North Central Cancer Treatment Group Study. J Clin Oncol 2004;22:1572-1582.